Singapore's Agency for Science, Technology and Research (A*STAR) and the National University of Singapore (NUS) launched a synthetic biology research facility to accelerate the commercialization of sustainable bio-based products, according to a ministry release on Thursday.
Named the A*STAR SIFBI-NUS Synthetic Biology Joint Lab, the facility will focus on artificial intelligence-guided enzyme and pathway engineering, industrially deployable microbial platforms, and novel compounds for ingredient and functional applications.
In the longer term, the platform aims to drive technology licensing, startup formation and industry partnerships, supporting the growth of Singapore's bio-based innovation ecosystem.